Connect with us


COVID-19: Ontario reports 172 new cases; fully vaccinated still need to get tested if symptomatic, says OPH – Ottawa Citizen



Article content

Ontario reported 172 additional cases of COVID-19 Sunday, bringing the seven-day average for new cases to 159 daily – up from 153 a week ago.


Article content

In terms of active cases, the hardest-hit regions are Porcupine (42 active cases per 100,000 people), Grey Bruce (26 per 100,000), Hamilton (22), Waterloo (21) and North Bay Parry Sound (15).

Ottawa, comparatively, has five active cases per 100,000, according to provincial reporting.

Two additional COVID-19-linked deaths were added to the provincial total, which sits at 9,313 lives lost since the pandemic began.

There are 92 COVID-19 patients in ICU testing positive, down from 107 a week ago. The latest ICU figure rises to 127, if you include those no longer testing positive.

Escapade Music Festival teamed up with Ottawa Public Health to run a vaccine clinic at RCGT Park, Saturday, July 24, 2021.
Escapade Music Festival teamed up with Ottawa Public Health to run a vaccine clinic at RCGT Park, Saturday, July 24, 2021. Photo by Ashley Fraser /Postmedia

In the last day in eastern Ontario, confirmed case counts rose by two in both Ottawa and the Eastern Ontario health unit region, and by one in Hastings Prince Edward. The case counts in Renfrew County and District and Kingston, Frontenac and Lennox & Addington were unchanged, while the count dropped by one in Leeds, Grenville & Lanark, which can happen when data is corrected or updated.


Article content

Close to 81 per cent of Ontario adults (18 and older) have received at least one dose of COVID-19 vaccine, while nearly 68 per cent are fully vaccinated.

Update on vaccinations in Ontario. Data distributed on July 25 at 10:28 a.m.
Update on vaccinations in Ontario. Data distributed on July 25 at 10:28 a.m. Photo by SUPPLIED /ONTARIO


Ottawa’s confirmed COVID-19 case count increased by one, in Sunday reporting by Ottawa Public Health. No additional COVID-19 deaths were logged in the last day.

The number of active cases across Ottawa’s population sits at 44, and there is one Ottawan with COVID-19 in hospital. OPH data lists no ongoing outbreaks.

Over the latest seven-day period (July 17 to 23), a total of 41 new cases were reported to OPH. That makes for a weekly rate of 3.9 per 100,000 people, well under the threshold for the green zone under the province’s old colour-coded COVID-19 response framework, which was associated with a weekly incidence rate of less than 10 per 100,000.


Article content

In the community, 0.5 per cent of Ottawans tested for COVID-19 got a positive result, for the week of July 16 to 22.

The latest seven-day average for estimated R(t) is 1.2. According to OPH, R(t) values greater than one indicate the virus is spreading faster, with each case infecting more than one contact.

There are plenty of places to secure a COVID-19 vaccination on Sunday.

Drop-in first and second doses are available between until 7 p.m. at the city-run Eva James Community Centre, Nepean Sportsplex, Orléans YMCA, and Ottawa City Hall clinics, and at the Queensway Carleton Hospital until 3 p.m.

Doses one and two are also available for drop-ins at a pop-up vaccination clinic at the AMA Community Centre (1216 Hunt Club Rd.) until 4:30 p.m.


Article content

And a note for people who’ve already been vaccinated: You still need to isolate and get tested for COVID-19 if you have symptoms, according to OPH guidance.

The health unit’s website advises that although the COVID-19 vaccines approved for use in this country are effective, it takes time to develop protection after getting the vaccine, and there will still be a small percentage of vaccinated people who are vulnerable to the virus.

“These people may be less likely to develop severe disease if infected with COVID-19. But they may still be able to spread COVID-19 to others,” OPH notes.

If you develop COVID-19 symptoms, even if you’re vaccinated, “it is important to understand that when you have close contact with people outside of your household, you are putting yourself and others at risk,” OPH says.


Article content



(reported Sunday)

172: New confirmed cases

549,2328: Total cases

2: New deaths

9,313: Total deaths

127: In ICU

80.8 per cent: Percentage of Ontario adults with at least one vaccine dose

67.8 per cent: Percentage of Ontario adults who are fully vaccinated


(reported Sunday)

1: New confirmed cases

27,775: Total cases

0: New deaths

593: Total deaths

44: Active cases

1: In hospital

0: In ICU

83 per cent: Percentage of adult population with at least one vaccine dose

69 per cent: Percentage of adult population that is fully vaccinated

  1. Rolande Fontaine receives the first dose of Moderna's COVID-19 vaccine at the Manoir Aimé-Léonard residence on Thursday March 11, 2021

    $1-million grand prize: Registration opens for Quebec vaccine lottery

  2. FILE: Kids wearing masks.

    Some parents, child cares, call for updates to COVID rules



Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

Adblock test (Why?)

Source link

Continue Reading


Tesla stock surges as Hertz orders 100,000 electric cars –



[unable to retrieve full-text content]

  1. Tesla stock surges as Hertz orders 100,000 electric cars
  2. Hertz to buy 100,000 Teslas for its rental fleet by next year
  3. Tesla soars on Hertz deal  CNBC Television
  4. The Hertz-Tesla Deal Will Help Normalize Electric Cars  Bloomberg
  5. Elon Musk Makes Tesla, Hertz and Bitcoin Memes Go Up  Bloomberg
  6. View Full coverage on Google News

Source link

Continue Reading


UBS logs surprise 9% rise in Q3 net profit



UBS posted a 9% rise in third-quarter net profit on Tuesday, as continued trading helped the world’s largest wealth manager to its best quarterly profit since 2015.

Its third-quarter net profit of $2.279 billion far outpaced a median estimate of $1.596 billion from a poll of 23 analysts compiled by Switzerland’s largest bank.

“Our business momentum, our focus on fueling growth, on disciplined execution and on delivering our full ecosystem to clients – all of this led to another strong quarter across all of our business divisions and regions,” Chief Executive Ralph Hamers said in a statement.

In each of the last four quarters, UBS saw double-digit percent gains in net profit as buoyant markets helped it generate higher earnings off of managing money for the rich.

From July through September, favourable market conditions, and higher lending and trading amongst its wealthy clientele, unexpectedly helped raise earnings over the bumper levels reported in the third quarter of last year.


(Reporting by Oliver Hirt and Brenna Hughes Neghaiwi; Editing by Michael Shields and Edwina Gibbs)

Continue Reading


Analysis: Capitol Hill drug pricing reform opponents among the biggest beneficiaries of pharma funds



Democratic Party lawmakers holding up proposed drug pricing reforms are among the largest beneficiaries of the pharmaceutical industry’s push to stave off price cuts, a Reuters analysis of public lobbying and campaign data shows.

The industry, which traditionally gives more to Republicans, channeled around 60% of donated campaign funds to Democrats this year. It has spent over $177 million on lobbying and campaign donations in 2021.

Nonprofit political action committees (PACs) run by Pfizer Inc and Amgen Inc and the Pharmaceutical Research and Manufacturers of America (PhRMA) were among the biggest donors, according to political spending data from OpenSecrets, formerly the Center for Responsive Politics.

Drugmakers are seeking to block laws that would give the U.S. government authority to negotiate prices for prescription medicines. Current U.S. law bars the government’s Medicare health insurance program from negotiating drug prices directly.

Many of the Democrats opposing an ambitious drug reduction bill proposed in the House of Representatives are among some of the biggest recipients of drug manufacturer lobbying funds.

They include Senators Kyrsten Sinema of Arizona, Robert Menendez of New Jersey, and Representative Scott Peters of California, OpenSecrets data covering industry donations through September of 2021 shows. In all, they have received around $1 million in pharmaceutical and health product industry donations this year.

A spokesperson for Sinema did not respond to a request for comment on the funds she has received but said the Senator supports making drugs as cheap as possible for patients.

Menendez and Peters said the donations did not influence their views. All three said they are opposed to The Lower Drug Costs Now Act, which is sponsored by Democrats in the House of Representatives and also known as H.R.3.

Menendez and Peters have advocated for alternative scaled-back drug pricing reforms that would still allow Medicare to negotiate drug prices but would lead to significantly smaller savings.

Congressman Frank Pallone of New Jersey, who is also one of the top recipients of drugmaker donations, voted in favor of H.R.3.

Sinema, who campaigned in 2018 on cutting drug prices, told the White House she opposes allowing Medicare to negotiate them. She received about $466,000 from the industry in 2021, according to OpenSecrets data.

Peters was the top recipient of pharmaceutical industry funds in the House this year at nearly $99,550, according to OpenSecrets data. A spokesperson said Peters was not influenced by lobbying money and opposed the proposed law to protect pharmaceutical industry jobs and innovation.

Drugmakers say the Democrats’ proposed drug price overhaul would undermine their ability to develop new medicines, an argument they have used whenever price cuts are discussed by politicians regardless of political party.

“Patients face a future with less hope under Congress’ current drug pricing plan,” PhRMA Chief Executive Steve Ubl said in an August statement in reference to the proposed law. PhRMA declined to comment on donating to key Democratic opponents of the bill.

The United States is an outlier as most other developed nations do negotiate drug prices with manufacturers.

Amgen did not immediately respond to requests for comment on its donations and Pfizer declined to comment.


President Joe Biden has vowed to cut medicine costs, in part by allowing the federal government to negotiate drug payments by Medicare, which covers Americans aged 65 and older.

But prospects for major drug pricing reforms have stalled in recent weeks amid opposition from centrist Democrats including Sinema and Peters. Negotiations are ongoing, eight Democratic staffers said.

The lawmakers’ resistance comes as 83% of Americans support allowing Medicare to negotiate medicine costs, according to a Kaiser Family Foundation poll. The United States spends more than twice as much per person on drugs as other wealthy economies, about $1,500, for a total of around $350 billion in 2019.

“Members of Congress don’t always mirror the views of the public and the pharmaceutical industry is a powerful lobbying force,” said Larry Levitt, a health economist at Kaiser.

The healthcare industry is the second largest industry lobbying group in the United States behind the finance sector. It donated more than $600 million to politicians ahead of the 2020 elections.

The pharmaceutical industry has spent hundreds of millions of dollars per year to sway federal and state policy. But current Democratic leadership has the industry concerned major reforms could actually be enacted and is working harder to offer alternatives such as reducing insurance co-pays, one industry source said. “It’s been sort of a mad scramble.”

Corporations in the United States are not permitted to make direct contributions to candidates but can give money through PACs. Most corporate PACs, including Pfizer’s and Amgen’s, are run by company managers and employees.

Democrats and some drug price experts say the Lower Drug Costs Now Act could save U.S. taxpayers and consumers billions annually with relatively minor impact on innovation.

A House Oversight and Reform Committee report showed that top drugmakers have spent around $50 billion more on share buybacks and dividends than research and development between 2016 and 2020.

Lovisa Gustafsson, a healthcare policy analyst at the Commonwealth Fund, a non-profit healthcare advocacy group, said, “There are other ways that we can incentivize innovation, aside from just paying huge margins for pharmaceutical companies.”


(Reporting by Ahmed Aboulenein in Washington and Carl O’Donnell in New York; Editing by Caroline Humer and Bill Berkrot)

Continue Reading